Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
24.40
+0.60 (2.52%)
At close: Mar 12, 2025

Vistin Pharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,0821,0511,033701859774
Upgrade
Market Cap Growth
1.72%1.72%47.47%-18.47%11.06%67.79%
Upgrade
Enterprise Value
1,0711,0531,034739809678
Upgrade
Last Close Price
24.4023.7021.6614.6918.0115.88
Upgrade
PE Ratio
17.2416.7522.66-34.56-
Upgrade
Forward PE
-9.459.459.459.459.45
Upgrade
PS Ratio
2.522.452.362.303.083.05
Upgrade
PB Ratio
3.503.403.202.563.122.84
Upgrade
P/TBV Ratio
3.403.403.202.563.122.84
Upgrade
P/FCF Ratio
16.8616.3814.21---
Upgrade
P/OCF Ratio
10.0110.0111.41-62.82-
Upgrade
PEG Ratio
1.721.721.721.721.721.72
Upgrade
EV/Sales Ratio
2.492.452.362.432.902.67
Upgrade
EV/EBITDA Ratio
10.2710.1012.18138.7118.9112.49
Upgrade
EV/EBIT Ratio
12.5612.3515.08-24.3314.89
Upgrade
EV/FCF Ratio
16.6916.4114.23---
Upgrade
Debt / Equity Ratio
0.010.010.010.180.01-
Upgrade
Debt / EBITDA Ratio
0.020.020.047.950.03-
Upgrade
Debt / FCF Ratio
0.030.030.05---
Upgrade
Asset Turnover
1.091.091.080.820.850.61
Upgrade
Inventory Turnover
1.911.912.162.192.572.62
Upgrade
Quick Ratio
0.990.991.230.621.923.38
Upgrade
Current Ratio
2.122.122.431.353.364.39
Upgrade
Return on Equity (ROE)
19.85%19.85%15.29%-1.72%9.07%-28.27%
Upgrade
Return on Assets (ROA)
13.52%13.52%10.58%-1.03%6.34%6.89%
Upgrade
Return on Capital (ROIC)
16.72%16.72%13.22%-1.27%7.56%8.27%
Upgrade
Return on Capital Employed (ROCE)
26.87%26.87%20.54%-11.38%15.72%
Upgrade
Earnings Yield
5.80%5.97%4.41%-0.67%2.89%-12.53%
Upgrade
FCF Yield
5.93%6.11%7.04%-10.68%-2.12%-25.70%
Upgrade
Dividend Yield
5.25%5.27%4.62%5.11%4.16%3.15%
Upgrade
Payout Ratio
123.64%123.64%--89.17%-
Upgrade
Total Shareholder Return
5.25%5.27%4.62%5.11%4.16%3.15%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.